These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8667903)

  • 21. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.
    Sauter ER; Wagner-Mann C; Ehya H; Klein-Szanto A
    Cancer Detect Prev; 2007; 31(1):50-8. PubMed ID: 17317033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
    Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
    Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.
    Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF
    Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drug (NSAID) use and levels of a lipid oxidation marker in plasma and nipple aspirate fluids.
    Kato I; Chen G; Djuric Z
    Breast Cancer Res Treat; 2006 May; 97(2):145-8. PubMed ID: 16322889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of nipple fluid for breast cancer screening.
    Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ
    Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter study.
    de Groot JS; Moelans CB; Elias SG; Hennink A; Verolme B; Suijkerbuijk KP; Jager A; Seynaeve C; Bos P; Witkamp AJ; Ausems MG; van Diest PJ; van der Wall E
    PLoS One; 2015; 10(5):e0127895. PubMed ID: 26000714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nipple fluid basic fibroblast growth factor in patients with breast cancer.
    Sartippour MR; Zhang L; Lu M; Wang HJ; Brooks MN
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2995-8. PubMed ID: 16365024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer.
    Lai LC; Erbas H; Lennard TW; Peaston RT
    Int J Cancer; 1996 Jun; 66(6):743-6. PubMed ID: 8647643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen production in the female breast: association with progesterone.
    Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
    Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
    Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of atypical epithelial hyperplasia in nipple aspirates of breast fluid.
    Petrakis NL; Wrensch MR; Ernster VL; Miike R; King EB; Goodson WH
    Lancet; 1987 Aug; 2(8557):505. PubMed ID: 2887789
    [No Abstract]   [Full Text] [Related]  

  • 34. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytologic and biochemical characteristics of breast fluid obtained through the nipple of non-lactating women].
    Vizoso F
    Med Clin (Barc); 1995 Sep; 105(9):349-56. PubMed ID: 7500690
    [No Abstract]   [Full Text] [Related]  

  • 36. Nipple aspirate fluid in epidemiologic studies of breast disease.
    Petrakis NL
    Epidemiol Rev; 1993; 15(1):188-95. PubMed ID: 8405203
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: The clinical usefulness of prostate specific antigen: update 1994.
    Diamandis EP; Yu H
    J Urol; 1996 Jan; 155(1):294; author reply 295. PubMed ID: 7490867
    [No Abstract]   [Full Text] [Related]  

  • 38. ASPO Distinguished Achievement Award Lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid.
    Petrakis NL
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):3-10. PubMed ID: 8420608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs.
    Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB
    Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.